Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 3

Research Article

GC-MS Analysis and Inhibitory Evaluation of Terminalia catappa Leaf Extracts on Major Enzymes Linked to Diabetes

Table 3

GC-MS identified phytochemicals present in T. catappa aqueous leaf extract.

Peak no.CompoundRetention time (min)Area (%)Molecular weight (g/mol)FormulaClassification of compound

12,3-Butanediol6.3992.1490.12C4H10O2Alcohol
2Diglycerol8.9583.31166.17C6H14O5Fatty acid
34H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-10.1052.03144.12C6H8O4Phenolics
4Benzofuran, 2,3-dihydro-11.1151.49120.15C8H8OPhenolics
52-Methoxy-4-vinylphenol12.3340.98150.17C9H10O2Phenolics
61,2,3-Benzenetriol13.4449.63126.11C6H6O3Phenolics
71,2,4-Benzenetriol13.584.65126.11C6H6O3Phenolics
82-Cyclohexen-1-one, 3-(hydroxymethyl)-6-(1-methylethyl)-14.2790.92168.23C10H16O2Terpenoid
99-Oxabicyclo[3.3.1]nonane-2,6-diol15.29511.02158.19C8H14O3Phenolics
10, 259,9-Dimethoxybicyclo[3.3.1]nona-2,4-dione15.4483.36212.24C11H16O4Phenolics
13, 159,10-Secocholesta-5,7,10(19)-triene-1,3-diol, 25-[(trimethylsilyl)oxy]-, (3β,5Z,7E)-15.8731.61212.24C30H52O3SiTerpenoid
148-Methyl-6-nonenoic acid16.1111.12170.25C10H18O2Fatty acid
11, 12, 16–19[1,1′-Bicyclopropyl]-2-octanoic acid, 2′-hexyl-, methyl ester16.9425.2322.50C21H38O2Fatty acid methyl ester
214-Decenoic acid, 3-methyl-, (E)-17.3221.39184.27C11H20O2Fatty acid
23Cycloheptanone imine, 2,2,7,7-tetramethyl-17.4882.52Alkaloid
24n-Hexadecanoic acid18.0496.77256.43C16H32O2Fatty acid
26Vitamin E18.5236.33430.70C29H50O2Terpenoid
27Jasmolin II18.5720.15374.50C22H30O5Pyrethrin
20, 22, 28Phytol18.9642.77296.50C20H40OPhytosterol
299,12-Octadecadienoic acid (Z,Z)-19.2146.39280.40C18H32O2Fatty acid
3017-Octadecynoic acid19.3188.31167.29C11H21NFatty acid

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.